| Medical and Health Sciences | Lifetime | 42 | GB 7 | 100.00 |
| Surgery | Lifetime | 6 | GB 1 | 99.99 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 3 | GB 2 | 99.97 |
| Medical Physiology | Lifetime | 180 | GB 18 | 99.72 |
| Epidemiology | Lifetime | 290 | GB 23 | 99.64 |
| Nutrition and Dietetics | Lifetime | 98 | GB 13 | 99.48 |
| Cardiology and Cardiovascular Medicine | Lifetime | 401 | GB 22 | 99.47 |
| Cancer Research | Lifetime | 358 | GB 26 | 97.90 |
| Clinical Pharmacology | Lifetime | 697 | GB 66 | 96.88 |
| Medical Biochemistry | Lifetime | 351 | GB 22 | 90.52 |
| Biotechnology | Lifetime | 656 | GB 41 | 87.24 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | Lifetime | 2 | GB 1 | 99.98 |
| Diet and metabolism studies | Lifetime | 9 | GB 1 | 99.95 |
| Lipoproteins and Cardiovascular Health | Lifetime | 4 | GB 1 | 99.97 |
| Cancer, Lipids, and Metabolism | Lifetime | 12 | GB 2 | 99.91 |
| Cholesterol and Lipid Metabolism | Lifetime | 5 | GB 2 | 99.89 |
| Diet, Metabolism, and Disease | Lifetime | 11 | GB 1 | 99.88 |
| Lipid metabolism and disorders | Lifetime | 3 | GB 1 | 99.84 |
| Fatty Acid Research and Health | Lifetime | 8 | GB 2 | 99.79 |
| Pharmacology and Obesity Treatment | Lifetime | 5 | GB 1 | 99.83 |
| Liver Disease Diagnosis and Treatment | Lifetime | 70 | GB 5 | 99.86 |
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 47 | GB 7 | 99.80 |
| Adipokines, Inflammation, and Metabolic Diseases | Lifetime | 53 | GB 5 | 99.65 |
| Drug Transport and Resistance Mechanisms | Lifetime | 93 | GB 6 | 99.45 |
| Cardiovascular Disease and Adiposity | Lifetime | 99 | GB 7 | 99.41 |
| Atherosclerosis and Cardiovascular Diseases | Lifetime | 98 | GB 8 | 99.11 |
| Microbial Metabolism and Applications | Lifetime | 61 | GB 7 | 98.44 |
| Adipose Tissue and Metabolism | Lifetime | 441 | GB 28 | 98.83 |
| Gallbladder and Bile Duct Disorders | Lifetime | 259 | GB 12 | 98.74 |
| Antioxidant Activity and Oxidative Stress | Lifetime | 201 | GB 12 | 98.46 |
| Nutrition, Genetics, and Disease | Lifetime | 137 | GB 26 | 97.93 |
| Cardiovascular Health and Risk Factors | Lifetime | 97 | GB 9 | 98.38 |
| Diabetes Treatment and Management | Lifetime | 343 | GB 36 | 98.69 |
| Pharmaceutical Economics and Policy | Lifetime | 123 | GB 17 | 97.93 |
| Metabolism, Diabetes, and Cancer | Lifetime | 624 | GB 60 | 97.76 |
| Peroxisome Proliferator-Activated Receptors | Lifetime | 434 | GB 24 | 97.11 |
| Lipid metabolism and biosynthesis | Lifetime | 304 | GB 26 | 97.01 |
| Plant biochemistry and biosynthesis | Lifetime | 506 | GB 26 | 96.99 |
| Antiplatelet Therapy and Cardiovascular Diseases | Lifetime | 657 | GB 45 | 97.16 |
| Gastroesophageal reflux and treatments | Lifetime | 686 | GB 56 | 96.69 |
| Natural Antidiabetic Agents Studies | Lifetime | 681 | GB 24 | 94.84 |
| Vitamin C and Antioxidants Research | Lifetime | 472 | GB 44 | 94.23 |
| Steroid Chemistry and Biochemistry | Lifetime | 640 | GB 45 | 89.94 |
| Lipoproteins and Cardiovascular Health | 2021-2025 | 612 | GB 22 | 89.64 |
